会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • 6-SUBSTITUTED ESTRADIOL DERIVATIVES AND METHODS OF USE
    • WO2011066542A3
    • 2011-06-03
    • PCT/US2010/058342
    • 2010-11-30
    • ENDECE INC.YARGER, James, G.
    • YARGER, James, G.
    • C07J1/00A61K31/565A61P35/00
    • Disclosed are compounds of the formula (I): where in R 1 , R 2 , R 3 and R 4 are independent l y hydrogen, C 1 -C 6 alkyl, halo, a sulfate, a glucuronide, -OH, a bulky group, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, N ( CH 2 ) n ; a phosphate group, and a phosphinate group; R 9 is hydrogen, halogen or alkyl; R11 i s selected from the group consisting of H, C 1 -C 6 alkyl, halogen, a sulfate, a glucoronide, - SO 2 NH 2 , -COOH, -CN, -CH 2 CN-, -NHCN-, -CHO, =CHOCH 3 , -COO salt, -0S0 2 alkyl, -NH 2 , and -NHCO ( CH 2 ) n; R 12 is selected from the group consisting o f H, a C 1 -C 6 alkyl, a sulfate, a glucoronide, a bulky group, aryl, cycloalkyl, heteroaryl and heterocycloalkyl; X i s selected from the group consisting of C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, halogen, a glucoronide, -NH 2 , - SO 2 NH 2 , -COOH, -CN, -CH 2 CN, -NHCN, -CHO, -COOsalt, -0S0 2 alkyl, - SH, - SCH 3 , -CH [ ( CH 2 ) n CH 3 ] COOCH 3 , - ( CH 2 ) mCOOCH 3 , - ( CH 2 U-O-CH 3 , - ( CH 2 ) m-0- ( CH 2 ) n CH 3 , ( CH 2 ) m - S -CH 3 , - ( CH 2 U- S - ( CH 2 ) n CH 3 , - ( CH 2 ) m -NH- ( CH 2 ) n CH 3 , -C 2 -C 8 alkenyl -0- ( CH 2 ) n CH 3 , - C 2 -C 8 alkenyl - S - ( CH 2 ) n CH 3 , -C 2 -C 8 alkenyl -N- ( CH 2 ) n CH 3 , -C 2 -C 8 alkynyl -O- ( CH 2 ) n CH 3 , -C 2 -C 8 alkynyl - S - ( CH 2 ) n CH 3 , -C 2 -C 8 alkynyl -N- ( CH 2 ) n CH 3 , - ( CH 2 U-OH, - ( CH 2 ) m -O-NH 2 , - ( CH 2 ) m - S -NH 2 , -NH ( CH 2 ) m CH 3 , -NH ( CH 2 ) m OCH 3 , -NH ( CH 2 ) m CHOH-COOH, -N ( CH 3 ) 2 , - ( CH 2 ) m (NH ) CH 2 OH, -NHCOOH, - ( CH 2 ) m NHCOOH, -NO 2 , - SCN, - S0 2 alkyl, -B ( OH ) 2 , - ( CH 2 ) m N ( CH 3 ) - SO 2 -NH 3 , - ( CH 2 ) m -NH- SO 2 -NH 2 ,-NHC ( = S) CH 3 , and -NHNH 2 ; and Y is selected from hydrogen, =0, -OCO(R 6 ) and -OH; wherein m is an integer between 0-20, n is an integer between 0-8, the symbol represents either a single or a double bond capable of forming a keto group at position 3 or 17; and the Λ/WV symbol represents any type of bond regardless of the stereochemistry; and the respective enantiomers, other stereochemical isomers, hydrates, solvates, tautomers and pharmaceutically acceptable salts of said compounds. The compounds are useful in the treatment of various types of cancer.